{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:07:50Z","timestamp":1792786070676,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"name":"University of Torino"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuro Oncol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1093\/neuonc\/nov167","type":"journal-article","created":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T20:09:02Z","timestamp":1441051742000},"page":"261-268","source":"Crossref","is-referenced-by-count":54,"title":["Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study"],"prefix":"10.1093","volume":"18","author":[{"given":"Roberta","family":"Rud\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Magistrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Franchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pellerino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Fiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morena","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Soffietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,8,30]]},"reference":[{"key":"2016012505373071000_18.2.261.1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e328317efe8"},{"key":"2016012505373071000_18.2.261.2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm046"},{"key":"2016012505373071000_18.2.261.3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq047"},{"key":"2016012505373071000_18.2.261.4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq009"},{"key":"2016012505373071000_18.2.261.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-010-0109-3"},{"key":"2016012505373071000_18.2.261.6","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199105000-00005"},{"key":"2016012505373071000_18.2.261.7","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<870::AID-CNCR18>3.0.CO;2-I"},{"key":"2016012505373071000_18.2.261.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-009-0879-6"},{"key":"2016012505373071000_18.2.261.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.10.039"},{"key":"2016012505373071000_18.2.261.10","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006394407245"},{"key":"2016012505373071000_18.2.261.11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21110"},{"key":"2016012505373071000_18.2.261.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2013.07.009"},{"key":"2016012505373071000_18.2.261.13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24524"},{"key":"2016012505373071000_18.2.261.14","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000158891.09531.11"},{"issue":"(3)","key":"2016012505373071000_18.2.261.15","first-page":"1023","article-title":"Response to temozolomide in supratentorial multifocal recurrence of malignant ependymoma","volume":"31","author":"Freyschlag","year":"2011","journal-title":"Anticancer Res"},{"key":"2016012505373071000_18.2.261.16","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0249-y"},{"key":"2016012505373071000_18.2.261.17","doi-asserted-by":"publisher","DOI":"10.3109\/02688697.2012.741740"},{"key":"2016012505373071000_18.2.261.18","doi-asserted-by":"publisher","DOI":"10.1159\/000355662"},{"key":"2016012505373071000_18.2.261.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043331"},{"key":"2016012505373071000_18.2.261.20","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","article-title":"Response criteria for phase II studies of supratentorial malignant glioma","volume":"8(7)","author":"Macdonald","year":"1990","journal-title":"J Clin Oncol"},{"key":"2016012505373071000_18.2.261.21","doi-asserted-by":"crossref","unstructured":"Newton HB Rud\u00e0 R Soffietti R . Ependymomas, neuronal and mixed neuronal-glial tumors, dysembroblastic neuroepithelial tumors, pleomorphic xanthoastrocytomas, and pilocytic astrocytomas. In Grisold W Soffietti R (eds), Handb Clin Neurol. 2012:551\u2013567.","DOI":"10.1016\/B978-0-444-53502-3.00008-2"},{"key":"2016012505373071000_18.2.261.22","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199108000-00006"},{"key":"2016012505373071000_18.2.261.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2009.04.024"},{"key":"2016012505373071000_18.2.261.24","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1187-2"},{"key":"2016012505373071000_18.2.261.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2014.05.011"},{"key":"2016012505373071000_18.2.261.26","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou162"},{"key":"2016012505373071000_18.2.261.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-009-1067-4"},{"key":"2016012505373071000_18.2.261.28","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou089"},{"key":"2016012505373071000_18.2.261.29","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70265-6"},{"key":"2016012505373071000_18.2.261.30","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70164-X"},{"key":"2016012505373071000_18.2.261.31","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2008.20.2.263"},{"key":"2016012505373071000_18.2.261.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2012.12.006"},{"key":"2016012505373071000_18.2.261.33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c1df34"},{"issue":"(5)","key":"2016012505373071000_18.2.261.34","first-page":"AT-23","article-title":"A Phase II Study of lapatinib and dose-dense temozolomide (TMZ) for adults with recurrent ependymoma: a CERN clinical trial [Abstract]","volume":"16","author":"Gilbert","year":"2014","journal-title":"Neuro Oncol"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/18\/2\/261\/7640563\/nov167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T08:49:28Z","timestamp":1503564568000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nov167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,30]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,1,23]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.1093\/neuonc\/nov167"],"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nov167","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,30]]}}}